Abstract
Cerebral venous thrombosis is associated with a variety of systemic illnesses, sepsis, pregnancy, coagulation defects, and autoimmune states. Deficiencies of antithrombin III, protein C, protein S, and factor V Leiden, or an increase in anticardiolipin A antibodies may be identified in patients with this disorder, but a precise pathogenesis may not be identifiable in 25% to 35% of patients.1 The disease is frequently overlooked clinically and on CT imaging, in part due to a low clinical suspicion of the disease stemming from its ability to simulate the clinical appearance of benign intracranial hypertension, neoplasms, encephalitis, or cerebrovascular accident.2 However, MRI with contrast, MR venography, and CT angiography all enhance reader sensitivity to this disease. The prognosis of the disease is unpredictable and variable. Mortality rates up to 33% can be reported depending on the underlying disease state and the presence or absence of hemorrhagic venous infarcts.3
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Deschiens MA, Conard J, Horellou MH, Ameri A, Preter M, Chedru F, Samama MM, Bousser MG (1996) Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 27: 1724–1730. 18.
Ameri A, Bousser MG (1994) Cerebral venous thrombosis: clinical diagnosis. Annales de Radiologie 37: 101–107.
Cantu C, Barinagarrementaria F (1993) Cerebral venous thrombosis associated with pregnancy and puerperium. 19. Stroke 24: 1880–1884.
Philips MF, Bagley LJ, Sinson GP, Raps EC, Galetta SL, Zager EL, Hurst RW (1999) Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 90: 20. 65–71.
Barnwell SL, Higashida RT, Halbach VV, Dowd CF, Hieshima GB (1991) Direct endovascular thrombolytic therapy for dural sinus thrombosis. Neurosurgery 28: 135–142. 21.
Barnwell SL, Clark WM, Nguyen TT (1994) Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR 22. 15: 1817–1822.
Holder CA, Bell DA, Lundell AL, Ulmer JL, Glazier SS (1997) Isolated straight sinus and deep cerebral venous thrombosis: successful treatment with local infusion of urokinase. Case report. J Neurosurg 86: 704–707.
Horowitz MB, Purdy P, Unwin H (1997) Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol 38: 58–67.
Kim SY, Suh JH (1997) Direct endovascular thrombolytic 25. therapy for dural sinus thrombosis: infusion of alteplase. AJNR 18: 639–645.
Smith TP, Higashida RT, Barnwell SL, Halbach VV, Dowd CF, Fraser KW, Teitelbaum GP, Hieshima GB (1994) Treatment of durai sinus thrombosis by urokinase infusion. AJNR 15: 801–807.
Spearman MP, Jungreis CA, Wehner JJ, Gerszten PC, Welch WC (1997) Endovascular thrombolysis in deep cerebral venous thrombosis. AJNR 18: 502–506.
Tsai FY, Higashida RT, Matovich V, Alfieri K (1992) Acute thrombosis of the intracranial durai sinus: direct thrombolytic treatment. AJNR 13: 1137–1141.
Frey JL, Muro GJ, Mcdougall CG, Dean BL, Jahnke HK (1999) Cerebral venous thrombosis. Combined intra- thrombus tPA and intravenous heparin. Stroke 30: 489–494.
Higashida RT, Helmer E, Halbach VV, Hieshima GB (1989) Direct thrombolytic therapy for superior sagittal sinus thrombosis. AJNR 10: S4 - S6.
Bagley LJ, Hurst RW, Galetta S, Teener J, Sinson GP (1998) Use of a microsnare to aid direct thrombolytic therapy of durai sinus thrombosis. AIR 170: 784–786.
Opatowsky MJ, Morris PP, Regan JD, Mewborne JD, Wilson JA (1999) Rapid thrombectomy of superior sagittal sinus and transverse sinus thrombosis with a rheolytic cath- eter device. AJNR 20: 414–417.
Dowd CF, Malek AM, Phatouros CC, Hemphili. JC 3RD (1999) Application of a rheolytic thrombectomy device in the treatment of durai sinus thrombosis: a new technique. AJNR 20:568–570.
Scarrow AM, Williams RL, Jungreis CA, Yonas H, Scarrow MR (1999) Removal of a thrombus from the sigmoid and transverse sinuses with a rheolytic thrombectomy catheter. AJNR 20: 1467–1469.
Wagner HJ, Stefan MH, Pitton MB, Weiss W, Wess M (1997) Rapid thrombectomy with a hydrodynamic catheter: results from a prospective, multicenter trial. Radiology 205: 675–681.
Sharafuddian MJA, Hicks ME, Jenson ML, Morris JE, Drasler WJ, Wison GJ (1997) Rheolytic thrombectomy with use of the Angiojet-F105 catheter: preclinical evaluation of safety. J Vasc Intervent Radial 8: 939–945.
Sharafuddin MIA, Hicks ME (1997) Current status of per-cutaneous mechanical thrombectomy, I. General Principles. J Vasc Intervent Radiol 8: 911–921.
Novak Z, Coldwell DM, Brega KE (2000) Selective infusion of urokinase and thrombectomy in the treatment of acute cerebral sinus thrombosis. AJNR 21: 143–145.
Einhäupl KM, Villringer A, Meister W (1991) Heparin treatment in sinus venous thrombosis. Lancet 338: 597–600.
Preter M, Tzourio C, Ameri A (1996) Long-term progno sis in cerebral venous thrombosis. Follow up of 77 patients. Stroke 27: 243–246.
Rael JR, OrrisonWw JR, Baldwin N, Sell J (1997) Direct thrombolysis of superior sagittal sinus thrombosis with coexisting intracranial hemorrhage. AJNR 18: 1238–1242.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Morris, P. (2002). Venous Thrombotic Disease. In: Interventional and Endovascular Therapy of the Nervous System. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3673-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3673-1_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-2903-7
Online ISBN: 978-1-4757-3673-1
eBook Packages: Springer Book Archive